Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Squamous Cell × talazoparib × 30 days × Clear all

Sponsor

Conditions

Neoplasm Metastasis 3 Breast Neoplasms 3 Prostatic Neoplasms 2 Ovarian Neoplasms 2 Neoplasms 2 mCRPC 1 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Leukemia 1 Hemangiosarcoma 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1

Interventions

Carboplatin 5 Cisplatin 4 pembrolizumab 3 Standard of Care 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy 2 Paclitaxel 2 Nivolumab 2 toripalimab 1 regorafenib 1 durvalumab 1 bavituximab 1 atezolizumab 1 aflibercept 1 Vitamin D 1 Tumor Burden 1 Tiragolumab 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Radiation 1 Quality of Life 1 Photochemotherapy 1 ON 01910 1 NEO212 1 Mohs Surgery 1 Lapatinib 1 Ipilimumab 1 IFL protocol 1 Histocompatibility Testing 1 Fluorouracil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡